Proteomics and Lipidomics to unveil the contribution of PCSK9 beyond cholesterol lowering: a narrative review

Proprotein convertase subtilisin/kexin type 9 (PCSK9), one of the key regulators of the low-density lipoprotein receptor (LDLR), can play a direct role in atheroma development. Although advances in the understandings of genetic PCSK9 polymorphisms have enabled to reveal the role of PCSK9 in the comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Gianazza, Erica, Macchi, Chiara, Banfi, Cristina, Ruscica, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291627/
https://www.ncbi.nlm.nih.gov/pubmed/37378405
http://dx.doi.org/10.3389/fcvm.2023.1191303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291627/
https://www.ncbi.nlm.nih.gov/pubmed/37378405
http://dx.doi.org/10.3389/fcvm.2023.1191303

Ejemplares similares